Table 3 Fatigue perception, general and cough-specific quality of life in patients with COPD and healthy people

12 ± 11 [%95 Cl 7–17]

6 ± 8 [%95 Cl 2–10]

0.058

9 ± 8 [%95 Cl 5–13]

5 ± 7 [%95 Cl 1–8]

0.064

20 ± 17 [%95 Cl 12–27]

97 ± 15 [%95 Cl 2–16]

0.046*

41 ± 35 [%95 Cl 24–57]

20 ± 29 [%95 Cl 6–33]

0.048*

4 ± 1 [%95 Cl 3–5]

3 ± 2 [%95 Cl 2–4]

0.503

43 ± 43 [%95 Cl 23–63]

8 ± 21 [%95 Cl -1-18]

0.03*

23 ± 28 [%95 Cl 10–35]

9 ± 14 [%95 Cl 2–15]

0.056

33 ± 27 [%95 Cl 20–46]

12 ± 19 [%95 Cl 3–22]

0.009*

31 ± 29 [%95 Cl 17–44]

11 ± 19 [%95 Cl 2–19]

0.015*

24 ± 21 [%95 Cl 14–34]

9 ± 12 [%95 Cl 3–15]

0.011*

27 ± 35 [%95 Cl 11–43]

5 ± 18 [%95 Cl -4-13]

0.018*

180 ± 144 [%95 Cl 113–248]

51 ± 62 [%95 Cl 22–80]

0.001*

5.3 ± 1.3 [%95 Cl 5–6]

6.7 ± 0.7 [%95 Cl 6–7]

0.001*

5.2 ± 1.2 [%95 Cl 5–6]

6.1 ± 0.4 [%95 Cl 5.9-6.2]

0.006*

5.7 ± 1.5 [%95 Cl 5–6]

6.9 ± 0.3 [%95 Cl 6.7-7]

0.004*

16.3 ± 3.8 [%95 Cl 12–17]

19.6 ± 1.3 [%95 Cl 19–20]

0.001*